mouse anti-human braf (v600e) antibody clone ve1 Search Results


99
NSJ Bioreagents cd20 antibody
Cd20 Antibody, supplied by NSJ Bioreagents, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd20 antibody/product/NSJ Bioreagents
Average 99 stars, based on 1 article reviews
cd20 antibody - by Bioz Stars, 2026-03
99/100 stars
  Buy from Supplier

90
Spring Bioscience mouse monoclonal igg2a antihuman braf v600e (clone ve1)
Mouse Monoclonal Igg2a Antihuman Braf V600e (Clone Ve1), supplied by Spring Bioscience, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse monoclonal igg2a antihuman braf v600e (clone ve1)/product/Spring Bioscience
Average 90 stars, based on 1 article reviews
mouse monoclonal igg2a antihuman braf v600e (clone ve1) - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

92
Abcam braf v600e antibody
Summary of genotype and phenotype of cohort
Braf V600e Antibody, supplied by Abcam, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/braf v600e antibody/product/Abcam
Average 92 stars, based on 1 article reviews
braf v600e antibody - by Bioz Stars, 2026-03
92/100 stars
  Buy from Supplier

98
Abcam mouse monoclonal anti braf
Characteristics of the radiogenic and sporadic papillary thyroid microcarcinomas in patients aged up to 30 years.
Mouse Monoclonal Anti Braf, supplied by Abcam, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse monoclonal anti braf/product/Abcam
Average 98 stars, based on 1 article reviews
mouse monoclonal anti braf - by Bioz Stars, 2026-03
98/100 stars
  Buy from Supplier

90
Cell Signaling Technology Inc braf v600e (ve1
Characteristics of the radiogenic and sporadic papillary thyroid microcarcinomas in patients aged up to 30 years.
Braf V600e (Ve1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/braf v600e (ve1/product/Cell Signaling Technology Inc
Average 90 stars, based on 1 article reviews
braf v600e (ve1 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
AbCys s a anti-human braf v600e antibody ve1
Characteristics of the radiogenic and sporadic papillary thyroid microcarcinomas in patients aged up to 30 years.
Anti Human Braf V600e Antibody Ve1, supplied by AbCys s a, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti-human braf v600e antibody ve1/product/AbCys s a
Average 90 stars, based on 1 article reviews
anti-human braf v600e antibody ve1 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
ProQinase GmbH b-raf v600e
Characteristics of the radiogenic and sporadic papillary thyroid microcarcinomas in patients aged up to 30 years.
B Raf V600e, supplied by ProQinase GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/b-raf v600e/product/ProQinase GmbH
Average 90 stars, based on 1 article reviews
b-raf v600e - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Millipore craf: raf-1
Characteristics of the radiogenic and sporadic papillary thyroid microcarcinomas in patients aged up to 30 years.
Craf: Raf 1, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/craf: raf-1/product/Millipore
Average 90 stars, based on 1 article reviews
craf: raf-1 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Spring Bioscience rabbit polyclonal antibody against kras
Characteristics of the radiogenic and sporadic papillary thyroid microcarcinomas in patients aged up to 30 years.
Rabbit Polyclonal Antibody Against Kras, supplied by Spring Bioscience, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit polyclonal antibody against kras/product/Spring Bioscience
Average 90 stars, based on 1 article reviews
rabbit polyclonal antibody against kras - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Biogenex mouse anti-human monoclonal antibodies against p53
Characteristics of the radiogenic and sporadic papillary thyroid microcarcinomas in patients aged up to 30 years.
Mouse Anti Human Monoclonal Antibodies Against P53, supplied by Biogenex, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse anti-human monoclonal antibodies against p53/product/Biogenex
Average 90 stars, based on 1 article reviews
mouse anti-human monoclonal antibodies against p53 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Millipore mek1 (millipore)
Characteristics of the radiogenic and sporadic papillary thyroid microcarcinomas in patients aged up to 30 years.
Mek1 (Millipore), supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mek1 (millipore)/product/Millipore
Average 90 stars, based on 1 article reviews
mek1 (millipore) - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

94
Cell Signaling Technology Inc braf v600e
Characteristics of the radiogenic and sporadic papillary thyroid microcarcinomas in patients aged up to 30 years.
Braf V600e, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/braf v600e/product/Cell Signaling Technology Inc
Average 94 stars, based on 1 article reviews
braf v600e - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier

Image Search Results


Summary of genotype and phenotype of cohort

Journal: The British Journal of Dermatology

Article Title: Does the gene matter? Genotype–phenotype and genotype–outcome associations in congenital melanocytic naevi [Link]

doi: 10.1111/bjd.18106

Figure Lengend Snippet: Summary of genotype and phenotype of cohort

Article Snippet: Cells were incubated overnight at 4 °C with BRAF V600E antibody 1 : 1000 (ab200535; Abcam, Cambridge, U.K.), with appropriate negative controls, followed by incubation with goat anti‐rabbit IgG‐conjugated Alexa Fluor 488 secondary antibody (A‐11034; Thermo Fisher Scientific) for 1 h at room temperature.

Techniques: Mutagenesis, Variant Assay

Sanger sequencing trace of DNA extracted directly from (a) congenital melanocytic naevus ( CMN ) tissue (upper) and DNA extracted from cultured naevus cells (lower) from the same patient, demonstrating BRAF c.1799T>A, p.(V600E) in both, which appears low‐level somatic in whole tissue and heterozygous in naevus cells. (b) A similar phenomenon is observed in naevus cells cultured directly from a patient with NRAS c183A>G, p.(Q61R). Immunocytochemistry of BRAF p.(V600E) naevus cells shows pancytoplasmic uniform expression of BRAF V600E (green) in all naevus cells. Cells are counterstained with Hoechst stain (blue) and Alexa Fluor 647‐conjugated phalloidin antibody (red). BRAF V600E negative control at original magnification × 20 (c), and BRAF V600E immunostaining at × 20 (d) and × 63 (e).

Journal: The British Journal of Dermatology

Article Title: Does the gene matter? Genotype–phenotype and genotype–outcome associations in congenital melanocytic naevi [Link]

doi: 10.1111/bjd.18106

Figure Lengend Snippet: Sanger sequencing trace of DNA extracted directly from (a) congenital melanocytic naevus ( CMN ) tissue (upper) and DNA extracted from cultured naevus cells (lower) from the same patient, demonstrating BRAF c.1799T>A, p.(V600E) in both, which appears low‐level somatic in whole tissue and heterozygous in naevus cells. (b) A similar phenomenon is observed in naevus cells cultured directly from a patient with NRAS c183A>G, p.(Q61R). Immunocytochemistry of BRAF p.(V600E) naevus cells shows pancytoplasmic uniform expression of BRAF V600E (green) in all naevus cells. Cells are counterstained with Hoechst stain (blue) and Alexa Fluor 647‐conjugated phalloidin antibody (red). BRAF V600E negative control at original magnification × 20 (c), and BRAF V600E immunostaining at × 20 (d) and × 63 (e).

Article Snippet: Cells were incubated overnight at 4 °C with BRAF V600E antibody 1 : 1000 (ab200535; Abcam, Cambridge, U.K.), with appropriate negative controls, followed by incubation with goat anti‐rabbit IgG‐conjugated Alexa Fluor 488 secondary antibody (A‐11034; Thermo Fisher Scientific) for 1 h at room temperature.

Techniques: Sequencing, Cell Culture, Immunocytochemistry, Expressing, Staining, Negative Control, Immunostaining

Characteristics of the radiogenic and sporadic papillary thyroid microcarcinomas in patients aged up to 30 years.

Journal: Frontiers in Endocrinology

Article Title: The high degree of similarity in histopathological and clinical characteristics between radiogenic and sporadic papillary thyroid microcarcinomas in young patients

doi: 10.3389/fendo.2022.970682

Figure Lengend Snippet: Characteristics of the radiogenic and sporadic papillary thyroid microcarcinomas in patients aged up to 30 years.

Article Snippet: In brief, a mouse monoclonal anti-BRAF (mutated V600E) antibody (VE1) ab228461(Abcam) at a 1:100 dilution and the Novolink Polymer Detection System (250T) (Leica RE7140-K) were used to detect IHC reaction product.

Techniques: Labeling, Dissection, Activity Assay

Characteristics of the radiogenic and sporadic papillary thyroid microcarcinomas in pediatric patients aged ≤ 18 years.

Journal: Frontiers in Endocrinology

Article Title: The high degree of similarity in histopathological and clinical characteristics between radiogenic and sporadic papillary thyroid microcarcinomas in young patients

doi: 10.3389/fendo.2022.970682

Figure Lengend Snippet: Characteristics of the radiogenic and sporadic papillary thyroid microcarcinomas in pediatric patients aged ≤ 18 years.

Article Snippet: In brief, a mouse monoclonal anti-BRAF (mutated V600E) antibody (VE1) ab228461(Abcam) at a 1:100 dilution and the Novolink Polymer Detection System (250T) (Leica RE7140-K) were used to detect IHC reaction product.

Techniques: Labeling, Dissection, Activity Assay

Characteristics of the radiogenic and sporadic papillary thyroid microcarcinomas in young adult patients aged 19-30 years.

Journal: Frontiers in Endocrinology

Article Title: The high degree of similarity in histopathological and clinical characteristics between radiogenic and sporadic papillary thyroid microcarcinomas in young patients

doi: 10.3389/fendo.2022.970682

Figure Lengend Snippet: Characteristics of the radiogenic and sporadic papillary thyroid microcarcinomas in young adult patients aged 19-30 years.

Article Snippet: In brief, a mouse monoclonal anti-BRAF (mutated V600E) antibody (VE1) ab228461(Abcam) at a 1:100 dilution and the Novolink Polymer Detection System (250T) (Leica RE7140-K) were used to detect IHC reaction product.

Techniques: Labeling, Dissection, Activity Assay

Characteristics of the radiogenic and sporadic papillary thyroid microcarcinomas sized up to 5 mm.

Journal: Frontiers in Endocrinology

Article Title: The high degree of similarity in histopathological and clinical characteristics between radiogenic and sporadic papillary thyroid microcarcinomas in young patients

doi: 10.3389/fendo.2022.970682

Figure Lengend Snippet: Characteristics of the radiogenic and sporadic papillary thyroid microcarcinomas sized up to 5 mm.

Article Snippet: In brief, a mouse monoclonal anti-BRAF (mutated V600E) antibody (VE1) ab228461(Abcam) at a 1:100 dilution and the Novolink Polymer Detection System (250T) (Leica RE7140-K) were used to detect IHC reaction product.

Techniques: Labeling, Dissection, Activity Assay

Sporadic recurrent MPTC sized 8 mm (pT1aN0M0 at the first operation) removed from a 22-year-old male patient: (A–D) primary tumor, (E–H) the RAI-R recurrent metastasis. (A) Nonencapsulated primary tumor with follicular-papillary (conventional) growth pattern with extrathyroidal extension to the connective tissue, H&E, 15X magnification. (B) Fragment of the primary tumor with papillary structures featuring tall cell areas and oncocytic changes, H&E, 400X magnification. (C) Primary tumor: positive IHC reaction with the anti-BRAF (mutated V600E) antibody, 400X magnification. (D) Primary tumor: IHC reaction with Ki67 (Clone MIB-1) antibody (Ki67 LI 3.1%), 400X magnification. (E) RAI-R recurrent metastasis with cystic changes removed 1.3 years after the first surgery, H&E, 15X magnification. (F) Fragment of the RAI-R recurrent metastasis with solid structure and oncocytic changes, H&E, 400X magnification. (G) fragment of the RAI-R recurrent metastasis: positive IHC reaction with anti-BRAF (mutated V600E) antibody, 400X magnification. (H) RAI-R recurrent metastasis: IHC reaction with Ki67 (Clone MIB-1) antibody (Ki67 LI 3.3%), 400X magnification.

Journal: Frontiers in Endocrinology

Article Title: The high degree of similarity in histopathological and clinical characteristics between radiogenic and sporadic papillary thyroid microcarcinomas in young patients

doi: 10.3389/fendo.2022.970682

Figure Lengend Snippet: Sporadic recurrent MPTC sized 8 mm (pT1aN0M0 at the first operation) removed from a 22-year-old male patient: (A–D) primary tumor, (E–H) the RAI-R recurrent metastasis. (A) Nonencapsulated primary tumor with follicular-papillary (conventional) growth pattern with extrathyroidal extension to the connective tissue, H&E, 15X magnification. (B) Fragment of the primary tumor with papillary structures featuring tall cell areas and oncocytic changes, H&E, 400X magnification. (C) Primary tumor: positive IHC reaction with the anti-BRAF (mutated V600E) antibody, 400X magnification. (D) Primary tumor: IHC reaction with Ki67 (Clone MIB-1) antibody (Ki67 LI 3.1%), 400X magnification. (E) RAI-R recurrent metastasis with cystic changes removed 1.3 years after the first surgery, H&E, 15X magnification. (F) Fragment of the RAI-R recurrent metastasis with solid structure and oncocytic changes, H&E, 400X magnification. (G) fragment of the RAI-R recurrent metastasis: positive IHC reaction with anti-BRAF (mutated V600E) antibody, 400X magnification. (H) RAI-R recurrent metastasis: IHC reaction with Ki67 (Clone MIB-1) antibody (Ki67 LI 3.3%), 400X magnification.

Article Snippet: In brief, a mouse monoclonal anti-BRAF (mutated V600E) antibody (VE1) ab228461(Abcam) at a 1:100 dilution and the Novolink Polymer Detection System (250T) (Leica RE7140-K) were used to detect IHC reaction product.

Techniques: